See the DrugPatentWatch profile for Exjade
Exjade's price is influenced by several factors, including insurance coverage, pharmacy, and the quantity purchased. A 30-count bottle of 500 mg Exjade tablets typically costs around $700 to $800 without insurance [1]. However, the actual out-of-pocket expense for patients can vary significantly.
How much does Exjade cost with insurance?
Insurance plans can substantially reduce the cost of Exjade. Many insurance providers offer coverage for this medication, but copay amounts differ based on the specific plan. Patients may be responsible for a copay ranging from $25 to over $100 per prescription [1]. It is advisable for patients to check with their insurance provider for precise coverage details and potential copay obligations.
Are there ways to get Exjade cheaper?
Several options exist to potentially lower the cost of Exjade. Patients can look for discount coupons or savings cards offered by the manufacturer or through third-party discount providers. Additionally, comparing prices at different pharmacies can reveal cost differences. In some cases, a 90-day supply might be more cost-effective than a 30-day supply [1].
What are the active ingredients in Exjade?
Exjade's active ingredient is deferasirox [2]. Deferasirox is an oral iron chelator used to treat chronic iron overload caused by blood transfusions [2].
What are the potential side effects of Exjade?
Common side effects of Exjade can include diarrhea, nausea, vomiting, abdominal pain, rash, and headache [3]. More serious side effects may occur, such as kidney problems, liver problems, and gastrointestinal bleeding [3]. Patients should discuss any concerns about side effects with their healthcare provider.
What is Exjade used for?
Exjade is prescribed to treat chronic iron overload in patients who have received blood transfusions [2]. This condition can occur in individuals with certain blood disorders, such as thalassemia, sickle cell disease, and myelodysplastic syndromes, leading to excess iron accumulation in organs like the liver and heart [2].
Are there alternatives to Exjade?
Another oral iron chelator available is Desferal (deferoxamine mesylate) [4]. While Desferal is also used to treat iron overload, it is typically administered via subcutaneous or intravenous infusion, making Exjade a more convenient oral option for many patients [4]. The choice between Exjade and other treatments depends on individual patient needs, medical history, and physician recommendations.
Who manufactures Exjade?
Exjade is manufactured by Novartis [5].
---
Sources:
[1] https://www.goodrx.com/exjade
[2] https://www.webmd.com/drugs/2/drug-151201/exjade-oral
[3] https://www.rxlist.com/exjade-side-effects-drug-center.htm
[4] https://www.hematology.org/education/patients/sickle-cell-disease/iron-overload
[5] https://www.drugs.com/exjade.html